EE200300519A - Meetod pioglitasooni kui suhkurtõvevastase aine saamiseks - Google Patents
Meetod pioglitasooni kui suhkurtõvevastase aine saamiseksInfo
- Publication number
- EE200300519A EE200300519A EEP200300519A EEP200300519A EE200300519A EE 200300519 A EE200300519 A EE 200300519A EE P200300519 A EEP200300519 A EE P200300519A EE P200300519 A EEP200300519 A EE P200300519A EE 200300519 A EE200300519 A EE 200300519A
- Authority
- EE
- Estonia
- Prior art keywords
- sup
- formula
- group
- residue
- general formula
- Prior art date
Links
- HYAFETHFCAUJAY-UHFFFAOYSA-N pioglitazone Chemical compound N1=CC(CC)=CC=C1CCOC(C=C1)=CC=C1CC1C(=O)NC(=O)S1 HYAFETHFCAUJAY-UHFFFAOYSA-N 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 3
- 239000003472 antidiabetic agent Substances 0.000 title abstract 2
- 229960005095 pioglitazone Drugs 0.000 title abstract 2
- 229940125708 antidiabetic agent Drugs 0.000 title 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract 2
- 125000003277 amino group Chemical group 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 abstract 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 abstract 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 229910052783 alkali metal Inorganic materials 0.000 abstract 1
- 150000001340 alkali metals Chemical group 0.000 abstract 1
- 230000003178 anti-diabetic effect Effects 0.000 abstract 1
- 239000002585 base Substances 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 230000005494 condensation Effects 0.000 abstract 1
- 238000009833 condensation Methods 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 230000003301 hydrolyzing effect Effects 0.000 abstract 1
- 150000002466 imines Chemical class 0.000 abstract 1
- 125000002560 nitrile group Chemical group 0.000 abstract 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-M phenolate Chemical compound [O-]C1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-M 0.000 abstract 1
- 229940031826 phenolate Drugs 0.000 abstract 1
- 125000006239 protecting group Chemical group 0.000 abstract 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CZ20011502A CZ20011502A3 (cs) | 2001-04-26 | 2001-04-26 | Způsob výroby antidiabetika |
| CZ20011501A CZ20011501A3 (cs) | 2001-04-26 | 2001-04-26 | Způsob výroby meziproduktu pro výrobu antidiabetika |
| PCT/CZ2002/000024 WO2002088120A1 (fr) | 2001-04-26 | 2002-04-25 | Procede de production d'un antidiabetique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE200300519A true EE200300519A (et) | 2004-02-16 |
Family
ID=25746959
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP200300519A EE200300519A (et) | 2001-04-26 | 2002-04-25 | Meetod pioglitasooni kui suhkurtõvevastase aine saamiseks |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7009057B2 (fr) |
| EP (1) | EP1387843B1 (fr) |
| AT (1) | ATE355286T1 (fr) |
| AU (1) | AU2002311057A1 (fr) |
| DE (1) | DE60218449D1 (fr) |
| EE (1) | EE200300519A (fr) |
| HU (1) | HUP0400091A2 (fr) |
| PL (1) | PL363738A1 (fr) |
| RU (1) | RU2281285C2 (fr) |
| SK (1) | SK14452003A3 (fr) |
| WO (1) | WO2002088120A1 (fr) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8993773B2 (en) | 2002-07-16 | 2015-03-31 | Cadila Healthcare Limited | Process to prepare pioglitazone via several novel intermediates |
| AU2003272072A1 (en) | 2002-07-16 | 2004-02-02 | Cadila Healthcare Limited | A process to prepare pioglitazone via several intermediates. |
| WO2004108721A1 (fr) * | 2003-04-01 | 2004-12-16 | Sun Pharmaceutical Industries Limited | Procede servant a preparer 5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-2,4-thiazolidinedione |
| ES2219180B1 (es) * | 2003-05-09 | 2006-03-01 | Medichem, S.A. | Compuesto intermedio util para la preparacion de pioglitazona. |
| WO2004101560A1 (fr) * | 2003-05-13 | 2004-11-25 | Synthon B.V. | Procedes de fabrication de derives de thiazolidinedione et composes associes |
| US7230016B2 (en) | 2003-05-13 | 2007-06-12 | Synthon Ip Inc. | Pioglitazone salts, such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same |
| US20070078170A1 (en) * | 2003-08-28 | 2007-04-05 | Khanduri Chandra H | Process for the preparation of pioglitazone |
| CN1319956C (zh) * | 2003-09-12 | 2007-06-06 | 深圳市海粤门生物科技开发有限公司 | 一种噻唑烷二酮的衍生物及其药用制剂的制备方法和应用 |
| EP1716144A2 (fr) | 2004-02-20 | 2006-11-02 | Synthon B.V. | Procedes pour produire de la pioglitazone et composes issus de ces procedes |
| US7402713B2 (en) * | 2006-03-07 | 2008-07-22 | E.I. Du Pont De Nemours And Company | Processes for conversion of tyrosine to p-hydroxystyrene and p-acetoxystyrene |
| ES2654908T3 (es) | 2006-03-16 | 2018-02-15 | Metabolic Solutions Development Company Llc | Análogos de tiazolidindiona para el tratamiento de enfermedades mediadas por una inflamación metabólica |
| EP2001469B1 (fr) | 2006-03-16 | 2012-05-23 | Metabolic Solutions Development Company LLC | Analogues de thiazolidinedione |
| KR100791400B1 (ko) | 2006-09-06 | 2008-01-07 | 동우신테크 주식회사 | 티아졸리딘디온 유도체의 제조방법 |
| US8304441B2 (en) | 2007-09-14 | 2012-11-06 | Metabolic Solutions Development Company, Llc | Thiazolidinedione analogues for the treatment of metabolic diseases |
| BRPI0817096B8 (pt) | 2007-09-14 | 2021-05-25 | Cirius Therapeutics Inc | análogo de tiazolidinodiona e composição farmacêutica que o compreende |
| WO2009148195A1 (fr) * | 2008-06-02 | 2009-12-10 | Daebong Ls, Ltd. | Composé de 5(4-hydroxybenzyl)thiazolidine-2,4-dione comme produit intermédiaire dans la synthèse de composés à base de thiazolidinedione et procédé de préparation de celui-ci |
| ES2658168T3 (es) | 2009-12-15 | 2018-03-08 | Cirius Therapeutics, Inc. | Sales de tiazolidinadiona ahorradoras de PPAR para el tratamiento de enfermedades metabólicas |
| CN108003090A (zh) * | 2018-01-05 | 2018-05-08 | 白银亿尔精细化工有限公司 | 一种制备4-[2-(5-乙基-2-吡啶基)乙氧基]硝基苯的方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57209274A (en) | 1981-06-16 | 1982-12-22 | Takeda Chem Ind Ltd | Urea derivative, its preparation and its use |
| WO1986006069A1 (fr) * | 1985-04-09 | 1986-10-23 | Takeda Chemical Industries, Ltd. | Derives de thiazolidinedione, leur procede de preparation et composition medicinale les contenant |
| AR240698A1 (es) * | 1985-01-19 | 1990-09-28 | Takeda Chemical Industries Ltd | Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales |
| JPS62205054A (ja) | 1986-03-05 | 1987-09-09 | Takeda Chem Ind Ltd | 尿素誘導体 |
| US5952509A (en) | 1996-06-27 | 1999-09-14 | Takeda Chemical Industries, Ltd. | Production of benzaldehyde compounds |
| JP4316787B2 (ja) * | 2000-01-11 | 2009-08-19 | 壽製薬株式会社 | エーテル又はアミド誘導体、その製法並びにそれを含有する糖尿病治療剤、 |
-
2002
- 2002-04-25 WO PCT/CZ2002/000024 patent/WO2002088120A1/fr not_active Ceased
- 2002-04-25 PL PL02363738A patent/PL363738A1/xx not_active Application Discontinuation
- 2002-04-25 AT AT02734989T patent/ATE355286T1/de not_active IP Right Cessation
- 2002-04-25 HU HU0400091A patent/HUP0400091A2/hu unknown
- 2002-04-25 SK SK1445-2003A patent/SK14452003A3/sk unknown
- 2002-04-25 RU RU2003134542/04A patent/RU2281285C2/ru not_active IP Right Cessation
- 2002-04-25 EP EP02734989A patent/EP1387843B1/fr not_active Expired - Lifetime
- 2002-04-25 EE EEP200300519A patent/EE200300519A/xx unknown
- 2002-04-25 DE DE60218449T patent/DE60218449D1/de not_active Expired - Lifetime
- 2002-04-25 US US10/475,099 patent/US7009057B2/en not_active Expired - Fee Related
- 2002-04-25 AU AU2002311057A patent/AU2002311057A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| PL363738A1 (en) | 2004-11-29 |
| SK14452003A3 (sk) | 2004-04-06 |
| ATE355286T1 (de) | 2006-03-15 |
| DE60218449D1 (de) | 2007-04-12 |
| AU2002311057A1 (en) | 2002-11-11 |
| HUP0400091A2 (hu) | 2004-06-28 |
| WO2002088120A1 (fr) | 2002-11-07 |
| RU2281285C2 (ru) | 2006-08-10 |
| RU2003134542A (ru) | 2005-06-10 |
| WO2002088120B1 (fr) | 2004-02-26 |
| US7009057B2 (en) | 2006-03-07 |
| EP1387843A1 (fr) | 2004-02-11 |
| US20050043360A1 (en) | 2005-02-24 |
| EP1387843B1 (fr) | 2007-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE200300519A (et) | Meetod pioglitasooni kui suhkurtõvevastase aine saamiseks | |
| MEP7808A (en) | Process for preparing 4-trifluoromethylsulphinylpyrazole derivative | |
| CO5280198A1 (es) | Inhibidores a base de pirrolidina fusionada con ciclopropilo de dipeptidil peptidasa iv y metodo | |
| CA2315481A1 (fr) | Inhibition selective de l'aggrecanase dans le traitement de l'arthrose | |
| DE60030877D1 (de) | Nichtkorrosive reinigungszusammensetzung zur entfernung von plasmaätzrückständen | |
| AU2482800A (en) | Sulphohydroxamic acids and sulphohydroxamates and their use as mek inhibitors | |
| WO2004020430A3 (fr) | Derives de dioxane-2-alkylcarbamates, leur preparation et leur application en therapeutique | |
| HUP0303166A2 (hu) | Eljárás 2-(6-helyettesített 1,3-dioxán-4-il)-ecetsav-származékok előállítására | |
| WO2003030886A3 (fr) | Allylamides utilises dans le traitement de la maladie d'alzheimer | |
| DE60211746D1 (de) | Aminosäurederivate zur behandlung der alzheimer-krankheit | |
| MXPA03001356A (es) | Nuevos agentes inhibidores de beta-amiloides, procedimientos para su preparacion y su uso como medicamentos. | |
| ATE245624T1 (de) | Verfahren zur herstellung substituierter allylamin derivative und deren salze | |
| AU3853697A (en) | N-benzenesulphonyl-l-proline derivatives as bradykinin b2 agonists | |
| EP1085015A3 (fr) | Catalyseur comprenant un composé hétérocyclique contenant de l'azote | |
| DE602004008863D1 (de) | Zusammensetzung und Verfahren zur Behandlung von Halbleitersubstraten | |
| AU2003303098A8 (en) | Process for the preparation of 2-aminomethylpyridine derivative | |
| WO2004024059A3 (fr) | Procede ameliore de fabrication de derives thiazolidinedione | |
| DE50203537D1 (de) | Verfahren zur Herstellung von primären und sekundären Aminen aus Nitrilen | |
| PT1317455E (pt) | Processo para a preparacao de um composto de imidazopiridina substituido | |
| EP1236709A3 (fr) | Procédé pour la préparation de terbinafine | |
| DE50202381D1 (de) | Geschützte tyrosinderivate, verfahren zu deren herstellung und deren verwendung zur herstellung von o-(2- ?18 f]-fluorethyl)-l-tyrosin | |
| TWI319768B (en) | Process for preparing polyarylate having high thermo-resistance and high transparency | |
| BR9910078A (pt) | Processo para fabricação de uréias 1,3-dissubstituìdas-4-oxocìclicas | |
| ATE528358T1 (de) | Verfahren zur herstellung einer azoverbindung | |
| EP1035125A3 (fr) | 2-Pyridylsilane, procédé pour le préparer et son utilisation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HC1A | Change of owner name |